Expression of p63 in cutaneous metastases

American Journal of Clinical Pathology

Volumn 128, Issue 5, 2007, Pages 753-758

  Kanitakis, Jean ^a   Chouvet, Brigitte ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Cutaneous metastases; p63; Skin

Indexed keywords

PROTEIN P63;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN METASTASIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 36248976092     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/BD3K8U7KD969Y07U     Document Type: Article

References (20)

1. Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398:708-713.
2. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2:305-316.
3. Wu G, Nomoto S, Hoque MO, et al. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 2003;63:2351-2357.
4. Koster M, Roop D. The role of p63 in development and differentiation of the epidermis. J Dermatol Sci. 2004;34:3-9.
5. Westfall M, Pietenpol J. p63: molecular complexity in development and cancer. Carcinogenesis. 2004;25:857-864.
6. Di Como C, Urist M, Babayan I, et al. p63 protein expression profiles in human normal and tumor tissues. Clin Cancer Res. 2001;8:494-501.
7. Reis-Filho JS, Torio B, Albegraria A, et al. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol. 2002;29:517-523.
8. Tsujita-Kyutoku M, Kiuchi K, Danbara N, et al. p63 expression in normal human epidermis and epidermal appendages and their tumors. J Cutan Pathol. 2003;30:11-17.
9. Takeuchi Y, Tamura A, Kamiya M, et al. Immunohistochemical analyses of p63 expression in normal human skin. Br J Dermatol. 2004;151:232-235.
10. Takeuchi Y, Tamura A, Kamiya M, et al. Immunohistochemical analyses of p63 expression in cutaneous tumours. Br J Dermatol. 2005;153:1230-1232.
11. Park HR, Min SK, Cho HD, et al. Expression profiles of p63, p53, survivin and hTERT in skin tumors. J Cutan Pathol. 2004;31:544-549.
12. Dellavalle RP, Walsh P, Marchbank A, et al. CUSP/p63 expression in basal cell carcinoma. Exp Dermatol. 2002;11:203-208.
13. Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK7, and CK20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31:145-152.
14. Ivan D, Hafeez Diwan A, Prieto V. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol. 2005;18:137-142.
15. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003;443:122-132.
16. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
17. Hill C, Yeh I. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol. 2005;123:36-44.
18. Kanitakis J, Al-Rifai I, Faure M, et al. Differential expression of T (Thomsen-Friedenreich) and Tn antigens in primary and metastatic carcinomas of the skin. J Clin Pathol. 1998;51:588-592.
19. Kanitakis J, Chouvet B, Claudy A, et al. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors. Am J Clin Pathol. 2004;122:85-89.
20. Sariya D, Ruth K, Adams-McDonnell R, et al. Clinicopathologic correlations of cutaneous metastases: experience from a cancer center. Arch Dermatol. 2007;143:613-620.